Jonathan Smith, Author at Labiotech.eu

About

Reporter for Labiotech. I hail from the UK. I was born in Bristol, studied Neuroscience in the University of Bristol, and trained mice in Eisai, Hertfordshire, for one year. I then tickled locusts for my Ph.D. at the University of Leicester, before eventually ending up here!
Out of the office, I travel, play video games and board games, drink beer and play the piano.

Articles by Jonathan Smith

Best in Biotech 15 May 2023

The six most advanced microbiome players aiming for the gut

After decades of research, gut microbiome therapies are beginning to reach the market. Here are six of the companies harnessing the power of the microbiome to develop treatments derived from…

May 15, 2023 - 7 minutesmins - By Jonathan Smith

In Depth 6 Mar 2023

The biggest private biotech investments in February 2023

The companies Aera Therapeutics, Hemab and Loam Bio bagged the biggest biotech investments in February 2023. Around the world, gene therapy, manufacturing and biomaterials attracted the most investor interest. Private…

March 6, 2023 - 4 minutesmins - By Jonathan Smith

In Depth 6 Feb 2023

The biggest private biotech investments in January 2023

The companies Asimov, BioRay Pharmaceuticals and Colossal Biosciences bagged the biggest biotech investments in January 2023. Around the world, synthetic biology players and firms developing treatments for hormonal disorders attracted…

February 6, 2023 - 4 minutesmins - By Jonathan Smith

Woman looking through a window and seeing biotechnology such as pills and vaccines. It indicates the biotech trends coming in the future

Best in Biotech 12 Jan 2023

The biggest biotech trends that will shape 2023

2023 has begun at full throttle. We have collected seven major biotech trends that industry experts are keeping an eye on over the next 12 months. Just like that, another…

January 12, 2023 - 9 minutesmins - By Jonathan Smith

In Depth 9 Jan 2023

The biggest private biotech investments in December 2022

The companies Apogee Therapeutics, Pulmocide and Qitan Technology bagged the biggest biotech investments in December 2022. Around the world, immunology and manufacturing players attracted the biggest funding rounds. We’ve hit…

January 9, 2023 - 3 minutesmins - By Jonathan Smith

Anastasiia Slynko cancer navignostics 744x368 1

In Depth 5 Jan 2023

Navignostics maps tumor proteomes to improve precision oncology

New cancer drugs are entering the market every year, but it’s hard to know which patients they benefit the most. The Swiss firm Navignostics is making spatial maps of the…

January 5, 2023 - 4 minutesmins - By Jonathan Smith

In Depth 22 Dec 2022

10 biotech companies to watch in 2023

2022 is coming to an end. Here is a list of biotech companies from around the world that we are keeping in our sights in 2023. The year 2022 has…

December 22, 2022 - 9 minutesmins - By Jonathan Smith

In Depth 20 Dec 2022

Ebvallo approval ushers in off-the-shelf T-cell immunotherapies

Patient-derived CAR-T immunotherapies have dominated the cancer immunotherapy space over the last decade. The EU approval of Atara Biotherapeutics' Ebvallo marks the first immunotherapy based on T cells sourced from…

December 20, 2022 - 6 minutesmins - By Jonathan Smith

Startup Scout 19 Dec 2022

Green Bioactives grows medicines in plant cells

Though plants may hold the key to new, effective medicines, sourcing these compounds sustainably is difficult. Green Bioactives devises eco-friendly ways to produce plant-derived drugs via plant cell cultures. For…

December 19, 2022 - 4 minutesmins - By Jonathan Smith

In Depth 15 Dec 2022

To avoid stagnation, the EU must refine its ATMP regulation

Over the decades, the EU has spearheaded the adoption of advanced therapy medicinal products (ATMPs) such as cell and gene therapies. However, changes are needed to ATMP regulations to keep…

December 15, 2022 - 8 minutesmins - By Jonathan Smith

cancer protein degradation sibylla biotech

Interview 14 Dec 2022

Sibylla Biotech: how physicists met biologists to discover new drugs

Discovering new drugs remains an inefficient, trial and error-based process. The founding team behind the Italian startup Sibylla Biotech explain how their interdisciplinary approach can speed up drug discovery in…

December 14, 2022 - 9 minutesmins - By Jonathan Smith

Startup Scout 13 Dec 2022

Biomemory is making DNA hard drives cheap and sustainable

The world is running out of ways to store the mountains of data we produce. Biomemory is creating DNA-based hard drives that could store this information cheaply, sustainably and for…

December 13, 2022 - 5 minutesmins - By Jonathan Smith

In Depth 5 Dec 2022

The biggest private biotech investments in November 2022

The companies Emalex Biosciences, Osler Diagnostics and TauRx Pharmaceuticals bagged the biggest biotech investments in November 2022. Around the world, oncology and cell therapy players attracted the biggest funding rounds.…

December 5, 2022 - 4 minutesmins - By Jonathan Smith

Best in Biotech 1 Dec 2022

Five apps powering the future of at-home HIV tests

The smartphone revolution is providing a promising tool to combat the human immunodeficiency virus (HIV) epidemic. We’ve listed five HIV test apps in development that could help people carry out…

December 1, 2022 - 8 minutesmins - By Jonathan Smith

immutep checkpoint inhibitor lag 3 cancer

Interview 29 Nov 2022

LAG-3: The next big checkpoint inhibitor target

Since their first approval a decade ago, immune checkpoint inhibitors have been gaining momentum in the treatment of cancer. The Australian-French firm Immutep explains why the immune checkpoint target LAG-3…

November 29, 2022 - 7 minutesmins - By Jonathan Smith

Miquel Vila Perelló gene therapy SpliceBio

Interview 28 Nov 2022

Breaking barriers to gene therapies for childhood rare diseases

The majority of known rare genetic diseases affect children, and gene therapies could help them live normal lives. Miquel Vila-Perelló, CEO and co-founder of the Spanish biotech SpliceBio, outlines how…

November 28, 2022 - 5 minutesmins - By Jonathan Smith

News and Trends 24 Nov 2022

Gene therapy approval “game changer” in hemophilia B treatment

The approval of CSL's gene therapy Hemgenix has ushered in a new era for hemophilia B treatment. With the addition of other approvals like Rocktavian and Upstaza, 2022 could be…

November 24, 2022 - 7 minutesmins - By Jonathan Smith

Ulrich dauer vivoryon alzheimers disease

Interview 23 Nov 2022

What recent mixed clinical results can teach about Alzheimer’s disease

2022 has provided mixed fortunes for companies aiming to slow Alzheimer’s disease. Ulrich Dauer, CEO of the German biotech Vivoryon, explains the lessons these events provide. The quest for a…

November 23, 2022 - 7 minutesmins - By Jonathan Smith

Startup Scout 21 Nov 2022

Osivax is designing future-proof influenza and Covid vaccines

Viruses causing influenza and COVID-19 continually evolve to escape our vaccine protections. The French firm Osivax is developing vaccines that are harder for the viruses to evade. Many life-saving vaccines…

November 21, 2022 - 5 minutesmins - By Jonathan Smith

Best in Biotech 17 Nov 2022

The hottest private biotech companies in Canada

Canada is well known for biotech innovations, with expertise in genomics, cell therapies and liquid biopsy. Here is a list of private healthcare biotech companies that have attracted big cash…

November 17, 2022 - 6 minutesmins - By Jonathan Smith

Newsletter Signup

"*" indicates required fields

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

The Biotech Perspective 2023

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering